LUMIGAN

This brand name is authorized in Austria, Australia, Brazil, Canada, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug LUMIGAN contains one active pharmaceutical ingredient (API):

1 Bimatoprost UNII QXS94885MZ - BIMATOPROST

Bimatoprost is a potent ocular hypotensive agent. It is a synthetic prostamide, structurally related to prostaglandin F2α (PGF2α), that does not act through any known prostaglandin receptors. Read about Bimatoprost

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LUMIGAN Eye drops, solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EE03	Bimatoprost	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues
Discover more medicines within S01EE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10046R, 10053D, 5551E, 8620Q
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501003601171312, 501003602176318, 501006601138311, 501006602134318
Country: CA	Health Products and Food Branch	Identifier(s): 02324997
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00265425, 01682007, 02667168, 02667205, 04446112, 05900524, 05900530, 06846264, 07111493, 10070148, 10070154, 10114756, 10114762, 10199497, 10353389, 10402538, 10408937, 10418137, 10637626, 10742004, 11522397, 11522405, 11542371, 12342935, 13350693, 14032995, 14215916, 14241144, 14275574, 15634182, 15656344, 17199253, 17558516
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.847-08-04, 30173-04-12
Country: EE	Ravimiamet	Identifier(s): 1198289, 1198290, 1459896, 1459908, 1612022, 1612033, 1638154
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 02205003, 02205003IP, 102205006
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 007275, 010706, 115209, 181536
Country: FR	Base de données publique des médicaments	Identifier(s): 60135981, 66203859
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 167478, 167479, 219097, 375928, 376738, 381475
Country: HK	Department of Health Drug Office	Identifier(s): 60394, 62570
Country: IE	Health Products Regulatory Authority	Identifier(s): 41901, 77154, 77404, 77432
Country: IT	Agenzia del Farmaco	Identifier(s): 035447022, 035447059
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319757Q1027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005610, 1029636, 1052831, 1052832, 1068565, 1068566, 1071583
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 467M2001
Country: NL	Z-Index G-Standaard	Identifier(s): 14748444
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 104655, 61506, 92681
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10164, 13594, 15430
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100127269, 100221672
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68880001, W68880002
Country: SG	Health Sciences Authority	Identifier(s): 14365P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 3983011, 3983012
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699490561287
Country: US	FDA, National Drug Code	Identifier(s): 0023-3205